LALPATHLABNSEDr. Lal Path Labs Ltd.· Healthcare ServicesHighNeutral
Announced Fri, 30 Jan, 2026 · 13:17 IST

Dr Lal PathLabs Q3 FY26: revenue 6598 M, PAT 914 M, 3rd interim dividend 3.5/share

Exceptional ItemResults RestatedResults View source PDFExplain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹1395.00
prior close
₹1403.00
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%-0.6% vs market
Healthcare Service Provider peers, median of 25sector+0.2%+0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.4
10m
+0.2
15m
-0.3
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3+0.9-0.6+0.2+0.1
Next day
+2.2-0.8+2.9+0.1+2.1
2d
+0.6+2.1-1.6+2.4-1.8
3d
+0.6+2.9-2.3+2.4-1.8
4d
+1.1+1.8-0.8+3.4-2.3
5d
+3.5+1.5+2.0+4.0-0.5
1w
+3.5+4.6-1.1+4.5-1.0
15d
+0.5+2.1-1.6+2.7-2.2
1m
+0.9-0.3+1.3-5.5+6.5
2m
-6.3-8.6+2.3-10.6+4.3
3m
-1.5+7.0-8.5-2.9+1.4
UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Lal PathLabs posted Q3 FY26 consolidated revenue from operations of 6,598 M (up 10.6% YoY) and PAT of 914 M (down 6.8% YoY). For 9M FY26, revenue was 20,602 M (up 10.8%) and PAT was 3,776 M (up 12.1%). Board declared 3rd interim dividend of 3.5 per share with record date Feb 5, 2026. Results carry a 301 M exceptional charge for Labour Codes impact on gratuity and leave liabilities. Bonus shares 1:1 were allotted on December 22, 2025, and EPS for prior periods is restated accordingly.

Likely market impact

Q3 PAT dipped YoY due to the one-time Labour Codes charge; underlying revenue and 9M PAT growth remain healthy; third interim dividend rewards shareholders.